Key result
ISG56/IFIT1 is primarily responsible for interferon-induced inhibition of parainfluenza virus type 5 protein synthesis by selectively inhibiting the translation of viral mRNAs.
ISG56/IFIT1 is identified as the primary mediator of interferon-induced inhibition of parainfluenza virus type 5 translation.
May suggest antiviral targets; leaves open translation from animal models to human parainfluenza therapies.
Interferon (IFN) induces an antiviral state in cells that results in alterations of the patterns and levels of parainfluenza virus type 5 (PIV5) transcripts and proteins. This study reports that IFN-stimulated gene 56/IFN-induced protein with tetratricopeptide repeats 1 (ISG56/IFIT1) is primarily responsible for these effects of IFN. It was shown that treating cells with IFN after infection resulted in an increase in virus transcription but an overall decrease in virus protein synthesis. As there was no obvious decrease in the overall levels of cellular protein synthesis in infected cells treated with IFN, these results suggested that ISG56/IFIT1 selectively inhibits the translation of viral mRNAs. This conclusion was supported by in vitro translation studies. Previous work has shown that ISG56/IFIT1 can restrict the replication of viruses lacking a 2'-O-methyltransferase activity, an enzyme that methylates the 2'-hydroxyl group of ribose sugars in the 5'-cap structures of mRNA. However, the data in the current study strongly suggested that PIV5 mRNAs are methylated at the 2'-hydroxyl group and thus that ISG56/IFIT1 selectively inhibits the translation of PIV5 mRNA by some as yet unrecognized mechanism. It was also shown that ISG56/IFIT1 is primarily responsible for the IFN-induced inhibition of PIV5.
No takes yet. Share an insight, caveat, or question.
Andrejeva et al. (2012) studied Parainfluenza virus type 5 (PIV5) infection. Interferon (IFN) treatment and ISG56/IFIT1 knockdown vs. Untreated cells or control cells without knockdown was evaluated on Viral protein synthesis and transcription levels. ISG56/IFIT1 is primarily responsible for interferon-induced inhibition of parainfluenza virus type 5 protein synthesis by selectively inhibiting the translation of viral mRNAs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: